Featured Archives - Page 7 of 22 - Life Sciences Times

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

June 5, 2025

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

THIS WEEK'S STORIES

Konovo Appoints Tim Albury as Chief Financial Officer to Support Growth of AI-Driven Healthcare Platform

June 4, 2025

Pheast Therapeutics Earns FDA Fast Track Designation for Experimental Ovarian Cancer Therapy PHST001

June 3, 2025

Cellares and Mitsui Fudosan to Launch Japan’s First Commercial-Scale Smart Factory for Cell Therapy Manufacturing

May 30, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Featured

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

ConcertAI Unveils AI-Powered Precision Suite to Revolutionize Oncology Research and Life Sciences

Most Read

IDEXX Launches In-Clinic Cortisol Test to Help Veterinarians Diagnose Canine Endocrine Disorders

Charter Next Generation Names Lisa Alteri as Chief Operating Officer to Drive Operational Strategy and Growth

Mediar Therapeutics Begins Phase 2 Trial of MTX-463 for Idiopathic Pulmonary Fibrosis

Genetic Marker Linked to Immunotherapy Resistance in Deadly Skin Cancer, NYU Study Finds

EDITOR PICKS

Casma Therapeutics Advances Novel Parkinson’s Drug Candidate Toward Clinical Trials

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

THIS WEEK'S STORIES

Konovo Appoints Tim Albury as Chief Financial Officer to Support Growth of AI-Driven Healthcare Platform

Pheast Therapeutics Earns FDA Fast Track Designation for Experimental Ovarian Cancer Therapy PHST001

Cellares and Mitsui Fudosan to Launch Japan’s First Commercial-Scale Smart Factory for Cell Therapy Manufacturing

POPULAR CATEGORY

ABOUT US

FOLLOW US